Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Tetranitromethane”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 145 records · Page 8Linked to original sources
PubMed1975

Temporal evolution of the sensitivity to tetranitromethane of the active site of anti-Tobacco mosaic virus antibodies.

Rabbit anti-TMV antibody taken 9 days after antigen injection is inactivated by much lower concentrations of tetranitomethane (TNM) than anti-body taken after 30 days. This change in sensitivity to TNM occurs in a very heterogeneous population of molecules, including IgM and IgG classes, but the affinity of the antibody remains unchanged. Thus, the phenomenon is not the result of selection of antibody-producing cells under the influence of antigen. Inactivation of early anti-TMV antibody appears to result from the nitration of one tyrosyl residue per Fab fragment. This tyrosine is probably located in the heavy chain and most probably in the variable portion. The moderate sensitivity of late anti-body to TNM is attributed to the lower reactivity of a tyrosine in the active site, and to the fact that nitration of this tyrosine does not inactivate the binding site. The suggested interpretation is that the majority of molecules of a very heterogeneous anti-TMV antibody pool may have a common structure in their active site during the early stage of the antibody response. This may later be replaced in most molecules by different structures.

Animals↗
PubMed1981

Effect of chemical modifiers of amino acid residues on proton conduction by the H+-ATPase of mitochondria.

The effect of chemical modifiers of amino acid residues on the proton conductivity of H+-ATPase in "inside out" submitochondrial particles has been studied. Treatment of submitochondrial particles prepared in the presence of EDTA (ESMP) with the arginine modifiers, phenylglyoxal or butanedione, or the tyrosine modifier, tetranitromethane, caused inhibition of the ATPase activity. Phenylglyoxal and tetranitromethane also caused inhibition of the anaerobic release of respiratory delta micro H+ in ESMP as well as in particles deprived of F1 (USMP). Butanedione treatment caused, on the contrary, acceleration of anaerobic proton release in both particles. The inhibition of proton release caused by phenylglyoxal and tetranitromethane exhibition in USMP a sigmoidal titration curve. The same inhibitory pattern was observed with oligomycin and with N,N'-dicyclohexylcarbodiimide. In ESMP, relaxation of delta micro H+ exhibited two first-order phases, both an expression of the H+ conductivity of the ATPase complex. The rapid phase results from transient enhancement of H+ conduction caused by respiratory delta micro H+ itself. Oligomycin, N,N'-dicyclohexylcarbodiimide, and tetranitromethane inhibited both phases of H+ release, and butanedione accelerated both. Phenylglyoxal inhibited principally the slow phase of H+ conduction. In USMP, H+ release followed simple first-order kinetics. Oligomycin depressed H+ release, enhanced respiratory delta micro H+, and restored the biphasicity of H+ release. Phenylglyoxal and tetranitromethane inhibited H+ release in USMP without modifying its first-order kinetics. Butanedione treatment caused biphasicity of H+ release from USMP, introducing a very rapid phase of H+ release. Addition of soluble F1 to USMP also restored biphasicity of H+ release. A mechanism of proton conduction by Fo is discussed based on involvement of tyrosine or other hydroxyl residues, in series with the DCCD-reactive acid residue. There are apparently two functionally different species of arginine or other basic residues: those modified by phenylglyoxal, which facilitate H+ conduction, and those modified by butanedione, which retard H+ diffusion.

Adenosine Triphosphatases↗